T cell recognition of the acetylcholine receptor in myasthenia gravis

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 283-308

  Conti Fine, Bianca M ^a,b   Navaneetham, Duraiswamy ^a,b   Karachunski, Peter I ^a,b   Raju, Raghavanpillai ^a,b,d   Diethelm Okita, Brenda ^a,b   Okita, David ^a,b   Howard Jr , James ^c   Wang, Zeng Yu ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHOLINERGIC RECEPTOR; DIPHTHERIA TOXOID; EPITOPE; RECEPTOR SUBUNIT; T LYMPHOCYTE RECEPTOR; TETANUS TOXOID;

AMINO ACID SUBSTITUTION; ANTIBODY PRODUCTION; CONFERENCE PAPER; CONTROLLED STUDY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; MULTIGENE FAMILY; MUSCLE BIOPSY; MYASTHENIA GRAVIS; RECEPTOR BINDING; SCID MOUSE; T LYMPHOCYTE ACTIVATION;

EID: 0031879167     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10936.x     Document Type: Conference Paper

References (78)

1. LINDSTROM, J. et al. 1988. Myasthenia gravis. Adv. Immunol. 42: 233-284.
2. SCHONBECK, S. et al. 1990. Myasthenia gravis: prototype of the antireceptor autoimmune diseases. Int. Rev. Neurobiol. 32: 175-200.
3. DRACHMAN, D. B. 1994. Myasthenia gravis. N. Engl. J. Med. 330: 1797-1810.
4. PROTTI, M. P. et al. 1993. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol. Today 14: 363-368.
5. CONTI-TRONCONI, B. M. et al. 1994. The nicotinic acetylcholine receptor: structure and autoimmune pathology. Crit. Rev. Biochem. Mol. Biol. 29: 69-123.
6. VANDENBARK, A. et al. 1992. TCR peptide therapy in autoimmune diseases. Int. Rev. Immunol. 2: 251-277.
7. SETTE, A. et al. 1994. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12: 413-431.
8. WALDOR, M. K. et al. 1983. In vivo therapy with monoclonal anti-I-A antibody suppresses immune response to acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 80: 2713-2717.
9. CHRISTADOSS, P. et al. 1986. Immuno-therapy for myasthenia gravis: a murine model. J. Immunol. 136: 2437-2440.
10. KAUL, R. et al. 1994. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis. J. Immunol. 152: 3152-3157.
11. ENGEL, A. G. et al. 1977. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiological correlation. Mayo Clin. Proc. 55: 2647-2680.
12. LENNON, V. A. et al. 1983. Autoantibodies to acetylcholine receptors in myasthenia gravis. N. Engl. J. Med. 308: 402-403.
13. MORGUTTI, M. et al. 1979. Cellular immune response to acetylcholine receptor in myasthenia gravis: thymectomy and corticosteroids. Neurology 29: 734-738.
14. + antibody: improvement correlates to decreased T-cell autoreactivity. Neurology 44: 1732-1737.
15. PENN, A., D. RICHMAN, R. RUFF & V. LENNON, Eds. 1993. Myasthenia Gravis and Related Disorders: Experimental and Clinical Aspects. Volume 681. Ann. N.Y. Acad. Sci. New York.
16. BOSNIA, G. C. et al. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
17. MCCUNE, J. M. et al. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241: 1632-1639.
18. MOSIER, D. E. et al. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256-259.
19. PFEFFER, K. et al. 1989. Adoptive transfer of human peripheral blood lymphocytes (PBL) into SCID mice. Curr. Top. Microbiol. Immunol. 152: 211-217.
20. MARTINO, G. et al. 1993. The human SCID myasthenic mouse model: a new approach for the study of myasthenia gravis. Ann. Neurol. 34: 48-56.
21. GU, Y. et al. 1988. Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron 1: 117-125.
22. HORTON, R. H. et al. 1993. The "embryonic" γ subunit of the nicotinic acetylcholine receptor is expressed in adult extrinsic ocular muscles. Neurology 43: 983-986.
23. KAMINSKI, H. J. et al. 1996. Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest. Ophthalmol. Visual Sci. 37: 345-351.
24. LINDSTROM, J. et al. 1978. Immunization of rats with polypeptide chains from Torpedo acetylcholine receptor causes an autoimmune response to receptors in rat muscle. Proc. Natl. Acad. Sci. U.S.A. 75: 769-773.
25. + cells. J. Immunol. 151: 1025-1038.
26. FUJII, Y. et al. 1988. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis: response to subunits and synthetic peptides. J. Immunol. 140: 1830-1837.
27. LINDSTROM, J. et al. 1991. Monoclonal antibody probes for nicotinic receptors of muscles and nerves. Biochem. Soc. Trans. 19: 115-120.
28. + T lines propagated with tetanus toxoid or with synthetic tetanus toxoid sequences. J. Autoimmun. 9: 79-88.
29. HOHLFELD, R. 1994. The thymus in myasthenia gravis. Neurol. Clin. North Am. 12: 331-343.
30. NELSON, S. et al. 1990. Adult thymus expresses an embryonic muscle acetylcholine receptor-like protein. J. Neuroimmunol. 29: 81-92.
31. GEUDER, K. I. et al. 1992. Pathogenetic significance of fetal-type acetylcholine receptors on thymic myoid cells in myasthenia gravis. Dev. Immunol. 2: 69-75.
32. STERN, L. J. et al. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
33. ODA, K. et al. 1981. Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis. J. Neurol. 225: 251-258.
34. HARA, H. et al. 1993. Nicotinic acetylcholine receptor mRNAs in myasthenic thymuses: association with intrathymic pathogenesis of myasthenia gravis. Biochem. Biophys. Res. Commun. 194: 1269-1275.
35. KAMINSKI, H. J. et al. 1993. Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve 16: 1332-1337.
36. SHENOY, M. et al. 1994. The pathogenic role of acetylcholine receptor α chain epitope within α146-162 in the development of experimental autoimmune myasthenia gravis in C57BL6 mice. Clin. Immunol. Immunopathol. 73: 338-343.
37. YEH, T. M. et al. 1990. T cells reactive with a small synthetic peptide of the acetylcholine receptor can provide help for a clonotypically heterogeneous antibody response and subsequently impaired muscle function. J. Immunol. 144: 1654-1660.
38. MILLER, S. D. et al. 1995. Evolution of the T cell repertoire during the course of experimental immuno-mediated demyelinating diseases. Immunol. Rev. 144: 225-244.
39. + T epitope repertoire on the human acetylcholine receptor a subunit in severe myasthenia gravis: a study with synthetic peptides. Neurology 42: 1092-1100.
40. MANFREDI, A. et al. 1993. T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis: epitopes on the γ and δ subunits. J. Clin. Invest. 92: 1055-1067.
41. + T cell response to human acetylcholine receptor α subunit correlates with myasthenia gravis severity: a study with synthetic peptides. J. Immunol. 144: 1276-1281.
42. PROTTI, M. P. et al. 1990. Immunodominant regions for T helper sensitization on the human nicotinic receptor a subunit in myasthenia gravis. Proc. Natl. Acad. Sci. U.S.A. 87: 7792-7796.
43. + cells of myasthenia gravis patients and healthy subjects. J. Clin. Invest. 93: 1020-1028.
44. PROTTI, M. P. et al. 1991. Myasthenia gravis: T epitopes of the δ subunit of human muscle acetylcholine receptor. J. Immunol. 146: 2253-2261.
45. + T epitopes on the embryonic γ subunit of human muscle acetylcholine receptor. J. Clin. Invest. 90: 1558-1567.
46. WANG, Z-Y. et al. 1997. Th1 epitope repertoire on the a subunit of human muscle acetylcholine receptor in myasthenia gravis. Neurology 48: 1643-1653.
47. WANG, Z-Y. et al. 1998. Th1 cells of myasthenia gravis patients recognize multiple epitopes on the muscle acetylcholine receptor a subunit. This volume.
48. CONTI-FINE, B. M. et al. 1996. Antibodies as tools to study the structure of membrane proteins: the case of the nicotinic acetylcholine receptor. Annu. Rev. Biophys. Biomol. Struct. 25: 197-229.
49. + T cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects. Eur. J. Immunol. 25: 3207-3214.
50. ROMAGNANI, S. 1995. Biology of human Th1 and Th2 cells. J. Clin. Immunol. 15: 121-129.
51. VOSKUHL, R. R. et al. 1993. T helper 1 (TH 1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15: 137-143.
52. CORREALE, J. et al. 1995. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J. Immunol. 154: 2959-2968.
53. VAN DER VEEN, R. et al. 1993. Fine specificity differences in the recognition of an encephalitogenic peptide by T helper 1 and 2 cells. J. Neuroimmunol. 48: 221-226.
54. YI, Q. et al. 1994. Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells. J. Neuroimmunol. 50: 177-186.
55. LINK, J. et al. 1994. Organ-specific autoantigens induce Interferon-γ and interleukin-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 44: 728-734.
56. + epitopes. J. Immunol. 152: 4686-4698.
57. LINK, H. et al. 1991. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87: 2191-2196.
58. WANG, Z-Y. et al. 1994. Induction of interferon-γ, interleukin-4, and transforming growth factor-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157: 353-368.
59. GU, D. et al. 1995. Myasthenia gravis-like syndrome induced by expression of interferon-γ in the neuromuscular junction. J. Exp. Med. 181: 547-557.
60. GAMMON, G. 1989. How some T cells escape tolerance induction. Nature 342: 183-185.
61. MONDINO, A. et al. 1994. Surface protein involved in T cell costimulation. J. Leukocyte Biol. 55: 805-815.
62. O'SULLIVAN, D. T. et al. 1991. On the interaction of promiscuous antigenic peptides with different DR alleles. J. Immunol. 147: 2663.
63. KARACHUNSKI, P. I. et al. 1997. Nasal administration of synthetic acetylcholine receptor T epitopes affects the immune response to the acetylcholine receptor and prevents experimental myasthenia gravis. J. Clin. Invest. In press.
64. + T cells in myasthenia gravis. J. Autoimmun. 10: 203-217.
65. MELMS, A. et al. 1993. T-cell receptor gene usage of acetylcholine receptor-specific T-helper cells. Ann. N.Y. Acad. Sci. 681: 313-314.
66. LANZAVECCHIA, A. et al. 1995. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181: 1945-1948.
67. LEHMANN, P. V. et al. 1993. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol. Today 14: 203-208.
68. MANFREDI, A. et al. 1994. Human acetylcholine receptor presentation in myasthenia gravis: DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. J. Immunol. 152: 4165-4174.
69. YUEN, M. H. 1996. MHC class II presentation of human acetylcholine receptor in myasthenia gravis: binding of synthetic γ subunit sequences to DR molecule. J. Autoimmun. 9: 67-77.
70. O'SULLIVAN, P. J. et al. 1990. Characterization of the specificity of peptide binding to four DR haplotypes. J. Immunol. 145: 1799-1808.
71. CHOE, S. et al. 1992. The crystal structure of diphtheria toxin. Nature 357: 216-222.
72. + T cells on tetanus toxin: identification of immunodominant sequence segments. J. Infect. Dis. 175: 382-391.
73. EISEL, Y. et al. 1986. Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins. EMBO J. 5: 2495-2502.
74. PANINA-BORDIGNON, P. et al. 1989. Study on the immunogenicity of human class-II-restricted T-cell epitopes: processing constraints degenerate binding, and promiscuous recognition. Cold Spring Harbor Symp. Quant. Biol. 54: 445-469.
75. REECE, J. C. et al. 1993. Mapping the major human T helper epitopes of tetanus toxin. J. Immunol. 151: 6175-6184.
76. HAMMER, J. et al. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181: 1847-1855.
77. HAMMER, J. et al. 1994. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl. Acad. Sci. U.S.A. 91: 4456-4460.
78. WUCHERPFENNIG, K. W. et al. 1995. Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181: 1597-1601.